This inventor holds 3 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Novartis Ag, Vernalis &r&d) Ltd.. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3,978 
2 out of 68 
Years Active: 2012-2015
Title: The Innovative Journey of Holger Petersen
Introduction
Holger Petersen, an inventive mind from Eimeldingen, Germany, has made significant contributions to the field of pharmaceuticals with a total of three patents to his name. His work focuses primarily on sustained release formulations and new salt forms of pharmaceutical compounds, showcasing his dedication to enhancing medical treatments and patient outcomes.
Latest Patents
Petersen's latest innovations include a patent for a sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers. This formulation aims to provide a consistent therapeutic effect over extended periods, crucial for patients requiring stable drug levels. Another notable patent involves new salt forms of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide. This invention highlights various forms, including mesylate, hydrochloride, tartrate, phosphate, and hemi-fumarate salts, ensuring diverse applications in treatment regimens for disorders mediated by Hsp90.
Career Highlights
Throughout his career, Holger Petersen has collaborated with prominent companies such as Novartis AG and Vernalis (R&D) Limited. His work in these esteemed organizations has significantly influenced pharmaceutical research and development, allowing him to refine his inventive skills and contribute valuable solutions to pressing medical needs.
Collaborations
In his journey as an inventor, Petersen has had the opportunity to work alongside notable colleagues, including Martin James Drysdale and Brian William Dymock. These collaborations not only enhanced his innovative capacity but also forged lasting relationships within the pharmaceutical research community.
Conclusion
Holger Petersen's contribution to the field of pharmaceutical innovations illustrates the importance of dedication, collaboration, and creativity in advancing medical science. With his continued focus on developing effective treatments through his patented inventions, he remains an influential figure in the realm of pharmaceutical research, dedicated to improving patient healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile